It is also used to reduce the risk of major cardiovascular events (such as heart attack, stroke, and cardiovascular death) in adults with type 2 diabetes and established heart disease
In both evoke and evoke+, participants received once-daily oral semaglutide or with a planned 2-year primary treatment phase and a subsequent 12-month extension
Eligibility criteria for Anthem Wegovy coverage Anthem usually covers Wegovy if you meet 1 or more of these criteria: Body mass index (BMI) of 30 or greater (classified as obesity) BMI of 27 to 29.9, plus at least 1 weight-related health condition (like diabetes, high blood pressure, or high cholesterol) Documented attempts at lifestyle interventions (diet and exercise) Prescription from a qualified healthcare provider (such as an endocrinologist, primary care provider, or obesity specialist) Criteria can vary based on your state and your specific Anthem plan, so its important to review your plans prescription coverage guidelines
Tran uses a gradual titration schedule, increasing your dose every four weeks only if your body has adjusted
The cumulative changes over months become undeniable when viewed side by side
Moreover, semaglutide outperformed liraglutide in safety and efficacy
